tm logo
OMNIVIUM PHARMA
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 22 Nov 2023

Last Applicant/ Owned by

2131 Felver Court, Suite A

Rahway

NJ

07065

Serial Number

90839919 filed on 21st Jul 2021

Registration Number

N/A

Correspondent Address

Michael C. Cannata

RIVKIN RADLER LLP

926 RXR PLAZA

UNIONDALE,NY 11556

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"PHARMA"

OMNIVIUM PHARMA

development of pharmaceutical preparations and medicines; pharmaceutical research and development; medical research; scientific research; scientific research and development "PHARMA" pharmaceutical products and preparations for curing, halting and preventing cardiovascular, bacterial, viral, psychiatric, eye, central nervous system, gastrointestinal, and cancer related diseases, easing symptoms,Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


development of pharmaceutical preparations and medicines; pharmaceutical research and development; medical research; scientific research; scientific research and development

Class [005]
Pharmaceutical Products


pharmaceutical products and preparations for curing, halting and preventing cardiovascular, bacterial, viral, psychiatric, eye, central nervous system, gastrointestinal, and cancer related diseases, easing symptoms, or helping in the diagnosis of illnesses; house mark for a full line of pharmaceuticals

Mark Details


Serial Number

No 90839919

Mark Type

No Service Mark

Attorney Docket Number

No 9943-6

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
24th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd Nov 2023SOU TEAS EXTENSION RECEIVED
22nd Nov 2023SOU EXTENSION 2 FILED
22nd Nov 2023SOU EXTENSION 2 GRANTED
24th May 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22nd May 2023SOU TEAS EXTENSION RECEIVED
22nd May 2023SOU EXTENSION 1 FILED
22nd May 2023SOU EXTENSION 1 GRANTED
22nd Nov 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27th Sep 2022PUBLISHED FOR OPPOSITION